ICAM1 and neoplasm: CD3-engaging BsAbs physically bridge cytotoxic T cells and tumor cells by binding CD3ε and a TAA, forming a functional immune synapse characterized by TCR microcluster assembly, LFA-1-ICAM-1 adhesion, and directed release of perforin and granzymes that induce tumor cell apoptosis.